Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 9—September 2003
Dispatch

Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan1

Po-Ren Hsueh*, Cheng-Hsiang Hsiao*, Shiou-Hwei Yeh†, Wei-Kung Wang*, Pei-Jer Chen*, Jin-Town Wang*, Shan-Chwen Chang*, Chuan-Liang Kao*Comments to Author , Pan-Chyr Yang*Comments to Author , and The SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital2
Author affiliations: *National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; †National Health Research Institute, Taipei, Taiwan

Main Article

Figure 2

Timelines of positive reverse-transcription polymerase chain reaction, antibody responses and treatment regimens (ribavirin, corticosteroid, and intravenous immunoglobulin) after onset of disease in seven patients with severe acute respiratory syndrome. Panels A–C indicate patients 1, 2, and 4.

Figure 2. Timelines of positive reverse-transcription polymerase chain reaction, antibody responses and treatment regimens (ribavirin, corticosteroid, and intravenous immunoglobulin) after onset of disease in seven patients with severe acute respiratory syndrome. Panels A–C indicate patients 1, 2, and 4.

Main Article

1The first and the second author contributed equally to this paper.

2The SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital includes the following: Ding-Shinn Chen, Yuan-Teh Lee, Che-Ming Teng, Pan-Chyr Yang, Hong-Nerng Ho, Pei-Jer Chen, Ming-Fu Chang, Jin-Town Wang, Shan-Chwen Chang, Chuan-Liang Kao, Wei-Kung Wang, Cheng-Hsiang Hsiao, and Po-Ren Hsueh.

Page created: January 03, 2011
Page updated: January 03, 2011
Page reviewed: January 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external